Insider Transactions in Q4 2020 at Deciphera Pharmaceuticals, Inc. (DCPH)
Insider Transaction List (Q4 2020)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 09
2020
|
Matthew L Sherman EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
207
+0.55%
|
$7,038
$34.43 P/Share
|
Dec 01
2020
|
Michael Douglas Taylor Director |
SELL
Open market or private sale
|
Direct |
19,000
-76.98%
|
$1,159,000
$61.55 P/Share
|
Dec 01
2020
|
Michael Douglas Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
19,000
+50.0%
|
$19,000
$1.89 P/Share
|
Nov 16
2020
|
Matthew L Sherman EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,697
+6.76%
|
$91,698
$34.43 P/Share
|
Nov 04
2020
|
Michael Douglas Taylor Director |
SELL
Open market or private sale
|
Direct |
15,000
-90.56%
|
$975,000
$65.01 P/Share
|
Nov 04
2020
|
Michael Douglas Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+50.0%
|
$15,000
$1.89 P/Share
|
Nov 02
2020
|
Michael Douglas Taylor Director |
SELL
Open market or private sale
|
Direct |
23,315
-69.73%
|
$1,328,955
$57.77 P/Share
|
Nov 02
2020
|
Michael Douglas Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
23,315
+50.0%
|
$23,315
$1.89 P/Share
|
Oct 09
2020
|
James Arthur Bristol |
SELL
Open market or private sale
|
Direct |
23,541
-92.5%
|
$1,271,214
$54.44 P/Share
|
Oct 09
2020
|
James Arthur Bristol |
BUY
Exercise of conversion of derivative security
|
Direct |
23,541
+50.0%
|
$23,541
$1.89 P/Share
|
Oct 02
2020
|
Matthew L Sherman EVP & Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,632
-7.16%
|
$134,232
$51.15 P/Share
|
Oct 01
2020
|
Michael Douglas Taylor Director |
SELL
Open market or private sale
|
Direct |
125,000
-90.45%
|
$6,375,000
$51.75 P/Share
|
Oct 01
2020
|
Michael Douglas Taylor Director |
BUY
Exercise of conversion of derivative security
|
Direct |
125,000
+32.0%
|
$125,000
$1.89 P/Share
|